Bone sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up, Ann Oncol, vol.21, pp.204-213, 2010. ,
Chemotherapy,en bloc resection, and prosthetic bone replacement in the treatment of osteogenic sarcoma, Cancer, vol.32, issue.1, pp.1-11, 1976. ,
DOI : 10.1002/1097-0142(197601)37:1<1::AID-CNCR2820370102>3.0.CO;2-3
Liposomal muramyl tripeptide phosphatidyl ethanolamine: a safe and effective agent against osteosarcoma pulmonary metastases, Expert Review of Anticancer Therapy, vol.8, issue.2, pp.151-154, 2008. ,
DOI : 10.1586/14737140.8.2.151
Mifamurtide for the treatment of nonmetastatic osteosarcoma, Expert Opinion on Pharmacotherapy, vol.50, issue.1, pp.285-292, 2011. ,
DOI : 10.1007/BF01741788
URL : https://hal.archives-ouvertes.fr/inserm-00667530
Effects of statins and farnesyltransferase inhibitors on the development and progression of cancer, Cancer Treatment Reviews, vol.30, issue.7, pp.609-641, 2004. ,
DOI : 10.1016/j.ctrv.2004.06.010
Suppression of murine neuroblastoma growth in vivo by mevinolin, a competitive inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme A reductase., Journal of Clinical Investigation, vol.76, issue.5, pp.761748-1754, 1985. ,
DOI : 10.1172/JCI112165